1
2
CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
Por Romanski, Annette, Uherek, Christoph, Bug, Gesine, Seifried, Erhard, Klingemann, Hans, Wels, Winfried S., Ottmann, Oliver G., Tonn, Torsten
Publicado no J Cell Mol Med (2016)
Obter o texto integralPublicado no J Cell Mol Med (2016)
Obter o texto integral
Obter o texto integral
Artigo
3